17-18492839-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000328114.11(LGALS9C):c.904G>A(p.Val302Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000466 in 1,501,176 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000328114.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LGALS9C | NM_001040078.3 | c.904G>A | p.Val302Ile | missense_variant | 10/11 | ENST00000328114.11 | NP_001035167.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LGALS9C | ENST00000328114.11 | c.904G>A | p.Val302Ile | missense_variant | 10/11 | 1 | NM_001040078.3 | ENSP00000329932 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000151 AC: 2AN: 132204Hom.: 0 Cov.: 23
GnomAD3 exomes AF: 0.0000780 AC: 16AN: 205138Hom.: 1 AF XY: 0.000135 AC XY: 15AN XY: 110754
GnomAD4 exome AF: 0.0000497 AC: 68AN: 1368972Hom.: 6 Cov.: 34 AF XY: 0.0000706 AC XY: 48AN XY: 680294
GnomAD4 genome AF: 0.0000151 AC: 2AN: 132204Hom.: 0 Cov.: 23 AF XY: 0.0000310 AC XY: 2AN XY: 64418
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.904G>A (p.V302I) alteration is located in exon 10 (coding exon 10) of the LGALS9C gene. This alteration results from a G to A substitution at nucleotide position 904, causing the valine (V) at amino acid position 302 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at